The role of m6A-associated membraneless organelles in the RNA metabolism processes and human diseases

6-methyladenosine (m6A) is the most abundant post-transcriptional dynamic RNA modification process in eukaryotes, extensively implicated in cellular growth, embryonic development and immune homeostasis. One of the most profound biological functions of m6A is to regulate RNA metabolism, thereby deter...

Full description

Saved in:
Bibliographic Details
Published in:Theranostics 2024-01, Vol.14 (12), p.4683-4700
Main Authors: Bu, Fang-Tian, Wang, Hai-Yan, Xu, Chao, Song, Kang-Li, Dai, Zhen, Wang, Lin-Ting, Ying, Jie, Chen, Jianxiang
Format: Article
Language:English
Subjects:
Adenosine - analogs & derivatives
Adenosine - metabolism
Animals
Cell Nucleus - metabolism
Cytoplasm - metabolism
Humans
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Organelles - metabolism
Review
RNA - metabolism
RNA Processing, Post-Transcriptional
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:6-methyladenosine (m6A) is the most abundant post-transcriptional dynamic RNA modification process in eukaryotes, extensively implicated in cellular growth, embryonic development and immune homeostasis. One of the most profound biological functions of m6A is to regulate RNA metabolism, thereby determining the fate of RNA. Notably, the regulation of m6A-mediated organized RNA metabolism critically relies on the assembly of membraneless organelles (MLOs) in both the nucleus and cytoplasm, such as nuclear speckles, stress granules and processing bodies. In addition, m6A-associated MLOs exert a pivotal role in governing diverse RNA metabolic processes encompassing transcription, splicing, transport, decay and translation. However, emerging evidence suggests that dysregulated m6A levels contribute to the formation of pathological condensates in a range of human diseases, including tumorigenesis, reproductive diseases, neurological diseases and respiratory diseases. To date, the molecular mechanism by which m6A regulates the aggregation of biomolecular condensates associated with RNA metabolism is unclear. In this review, we comprehensively summarize the updated biochemical processes of m6A-associated MLOs, particularly focusing on their impact on RNA metabolism and their pivotal role in disease development and related biological mechanisms. Furthermore, we propose that m6A-associated MLOs could serve as predictive markers for disease progression and potential drug targets in the future.
ISSN:1838-7640
1838-7640
DOI:10.7150/thno.99019